Search
for
Sort by
Research 541–570 of 1000+
- Helicobacter pylori infection and skin disorders
- Submental fat reduction by mesotherapy using phosphatidylcholine alone vs. phosphatidylcholine and organic silicium: a pilot study
- Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- ProjectH: a collaborative quantitative study of computer-mediated communication
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case‐series of 64 patients
- Nourkrin®: Objective and Subjective Effects and Tolerability in Persons with Hair Loss
- Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
- Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia
- Platelet-Rich Plasma and Stem Cells for Hair Growth: A Review of the Literature
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Effect of dietary supplementation with INVERSION® femme on slimming, hair loss, and skin and nail parameters in women
- Desideratum dermatologicum--cause and control of premenstrual acne flare
- Can plant‐derived phytochemicals provide symptom relief for hair loss? A critical review
- Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Bupropion for the treatment of fluoxetine non-responsive trichotillomania: a case report
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Therapeutic use of caffeine in dermatology: A literature review
- Pregnancy and the hair growth cycle: anagen induction against hair growth disruption using Nourkrin<sup>®</sup> with Marilex<sup>®</sup>, a proteoglycan replacement therapy
- Saw palmetto and finasteride in the treatment of category-iii prostatitis/chronic pelvic pain syndrome
- Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?
- [Photographic documentation of the effectiveness of 1 mg. oral finasteride in treatment of androgenic alopecia in the man in routine general practice in Switzerland].
- WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH
- Safety and tolerability of low-dose oral minoxidil in adolescents: A retrospective review
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity